Menu
Recruiting NCT03692884

Chongqing Diabetes Registry Study

— Observational Diabetes Mellitus

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Diabetes Mellitus. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Chongqing Diabetes and Its Chronic Complications Registry Study

Overview

To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.

Detailed description

This study is a prospective cohort study. About 5000 patients with diabetes from the Chongqing Diabetes Centre,Chongqing,China, will be enrolled for long-term follow-up.Information on socio-demographic parameters, medical history, current drug use,lifestyle factors, anthropometric measurements, metabolic control indicators and diabetes complications examination will be documented. Blood and urine samples will be collected. This study aimed to assess risk factors and biomarkers of occurrence and development of diabetic microvascular disease,macrovascular disease and neuropathy in patients with diabetes.

Primary outcome measures

  • The number of patients whoes Diabetic Kidney disease (DKD) is worsen [Time frame: 5 years]
Secondary outcome measures (6)
  • The number of patients who develop DKD [Time frame: 5 years]
  • The number of patients who develop Diabetic Retinopathy [Time frame: 5 years]
  • The number of patients whoes DR is worsen [Time frame: 5 years]
  • The number of patients who develop Diabetic Neuropathy [Time frame: 5 years]
  • The number of patients who develop Cardiovascular events [Time frame: 10 years]
  • The number of patients who develop Diabetic foot [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • Diagnosis of diabetes mellitus（based on the 1999 WHO diagnostic cretirial）;
  • Age younger than 75 years old, gender is not limited;
  • Voluntary to sign on the informed consent.

Exclusion criteria

  • pregnant or breast-feeding women;
  • Patients with chronic disease requiring long-term glucocorticoid therapy;
  • Patients with severe infection (except for diabetic foot) or immune dysfunction.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

China · 1 center
  • Qifu Li — Chongqing

Publications

  • Lv L, Zhou Y, Chen X, Gong L, Wu J, Luo W, Shen Y, Han S, Hu J, Wang Y, Li Q, Wang Z; Chongqing Diabetes Registry Group. Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2021 Jul 17;14:3299-3306. doi: 10.2147/DMSO.S318255. eCollection 2021. PMID 34305401

Identifiers

NCT: NCT03692884 · CDR2018

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗